Roivant Sciences (ROIV) Insider Trading & Ownership $11.57 +0.07 (+0.61%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Roivant Sciences (NASDAQ:ROIV) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.90%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$82.46 M Get ROIV Insider Trade Alerts Want to know when executives and insiders are buying or selling Roivant Sciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ROIV Insider Buying and Selling by Quarter Ad Behind the Markets⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Click here for the ticker >>> Roivant Sciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/18/2024Mayukh SukhatmeCIOSell412,584$12.05$4,971,637.20 11/20/2024Eric VenkerCOOSell100,000$11.32$1,132,000.00 10/21/2024Eric VenkerCOOSell100,000$11.65$1,165,000.00 9/26/2024Financial Lp QvtDirectorSell876,000$11.82$10,354,320.00 9/24/2024Keith S ManchesterDirectorSell368,052$11.62$4,276,764.24 9/23/2024Matthew GlineCEOSell1,983,257$11.79$23,382,600.03 9/23/2024Rakhi KumarCAOSell250,000$11.89$2,972,500.00 2/9/2024Eric VenkerCOOSell96,950$10.92$1,058,694.00 1/2/2024Vivek RamaswamyMajor ShareholderSell3,000,000$11.05$33,150,000.00 (Data available from 1/1/2013 forward) ROIV Insider Trading Activity - Frequently Asked Questions Who is on Roivant Sciences's Insider Roster? The list of insiders at Roivant Sciences includes Eric Venker, Financial Lp Qvt, Global Investors Lp Viking, Keith S Manchester, Matthew Gline, Mayukh Sukhatme, Pharma Technologies Ltd Dexcel, Rakhi Kumar, Richard Pulik, Sciences Ltd. Roivant, Svf Investments (Uk) Ltd, and Vivek Ramaswamy. Learn more on insiders at ROIV. What percentage of Roivant Sciences stock is owned by insiders? 7.90% of Roivant Sciences stock is owned by insiders. Learn more on ROIV's insider holdings. Which Roivant Sciences insiders have been buying company stock? The following insider purchased ROIV shares in the last 24 months: Sciences Ltd. Roivant ($58,000,008.00). How much insider buying is happening at Roivant Sciences? Insiders have purchased a total of 1,526,316 ROIV shares in the last 24 months for a total of $58,000,008.00 bought. Which Roivant Sciences insiders have been selling company stock? The following insiders have sold ROIV shares in the last 24 months: Eric Venker ($29,887,999.99), Financial Lp Qvt ($10,354,320.00), Global Investors Lp Viking ($128,700,000.00), Keith S Manchester ($83,927,227.44), Matthew Gline ($23,382,600.03), Mayukh Sukhatme ($4,971,637.20), Rakhi Kumar ($6,197,716.86), Richard Pulik ($15,448.96), Svf Investments (Uk) Ltd ($222,000,000.00), and Vivek Ramaswamy ($64,950,000.00). How much insider selling is happening at Roivant Sciences? Insiders have sold a total of 55,865,132 Roivant Sciences shares in the last 24 months for a total of $574,386,950.48 sold. Roivant Sciences Key ExecutivesMr. Matthew Gline (Age 40)CEO & Director Compensation: $1.77M1 recent tradesDr. Eric Venker M.D. (Age 37)Pharm.D., President & COO Compensation: $1.28MDr. Mayukh Sukhatme M.D. (Age 48)President, Chief Investment Officer & Director Compensation: $1.72MMr. Richard Pulik (Age 45)Chief Financial Officer Ms. Rakhi Kumar (Age 44)Chief Accounting Officer 1 recent tradesDr. Huafeng Xu Ph.D.Chief Technology OfficerMr. Jo ChenGeneral CounselMs. Kelly GraffHead of PeopleMs. Marianne L. Romeo (Age 56)Head of Global Transactions & Risk Management Mr. Alex GasnerExecutive Vice President of Roivant Health More Insider Trading Tools from MarketBeat Related Companies BNTX Insider Trading TEVA Insider Trading BGNE Insider Trading MRNA Insider Trading VTRS Insider Trading SMMT Insider Trading GMAB Insider Trading SRPT Insider Trading CTLT Insider Trading PCVX Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:ROIV) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roivant Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Roivant Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ROIV Stock Alerts